Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand.

Immodulon Therapeutics Ltd., a subsidiary of Lifexx SA, is a company headquartered in Uxbridge, UK, that develops treatments for cancer. It was founded in 2007 by John L. Stanford and Charles Akle. Cellia Habita is currently the CEO of the firm.\nThe company says this about itself: Immodulon Therapeutics Ltd. is a privately-owned clinical-stage immuno-oncology company primarily focused on the development of safe, effective and novel treatments for cancer. Its lead drug candidate, IMM-101, has shown promise in early clinical trials, demonstrating potential for the platform. It contains heat-killed whole cell Mycobacterium obuense which activates dendritic cells and other cells of the innate immune system by several mechanisms, including via Toll-like receptors. Its mechanism of action should not only make this product applicable to a range of cancers but, in combination with immune checkpoint inhibitors and other standard-of-care treatments, it is expected to enhance their efficacy without increasing the safety burden for the patient.

Daicel Corp. engages in the manufacture and sale of chemical products. It operates through the following segments: Cellulosic Derivatives, Organic Chemicals, Plastics, Pyrotechnic Devices, and Others. The Cellulosic Derivatives segment engages in the production of various cellulosic derivatives such as cellulose acetate, acetate tow for cigarette filters, and water-soluble polymers. The Organic Chemicals segment offers various solvents and fine chemicals; acetic acid, and chiral columns used for separation of optical isomers. The Plastic segment develops unique products for numerous industrial sectors such as engineering plastics, polymer alloys and cyclic-olefin copolymers; and also develops a variety of plastic processed products such as polystyrene sheets, formed trays, and functional films. The Pyrotechnic Devices segment provides motor vehicle safety devices, airbag inflators, aerospace and defense systems. The Others segment includes membrane and warehousing business. The company was founded on September 8, 1919 and is headquartered in Osaka, Japan.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Qiagen Hamburg GmbH, part of QIAGEN NV, is a company headquartered in Hilden, Germany. The firm provides healthcare services. It was founded in 2013. Roland Sackers and Peer Michael Schatz are the current co-CEOs of the firm.\nThe company says this about itself: QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis. We have developed more than 500 consumable products and automated solutions. We sell these products to academic research markets, to leading pharmaceutical and biotechnology companies, to molecular diagnostics laboratories as well as to customers in applied testing markets such as forensics, animal or food testing, and pharmaceutical process control.

Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. Its main products are meningococcal group A&C conjugate vaccine, meningococcal polysaccharide vaccine, mycobacterium vaccae, Haemophilus Influenzae type b conjugate vaccine, and freeze-dried live attenuated hepatitis A vaccine. Its other activities are biotechnology research, development, and consulting; import and export, and storage services. The company was founded on July 20, 1995 and is headquartered in Chongqing, China.

Beijing Zhifei Green Bamboo Bio-Pharmaceutical Co., Ltd., established on 2003-10-08, The scope of business includes the production of vaccines;Dedicated transport of goods(Refrigerated)(The road transport business license is valid until2024year08moon19day);Biological product,medicine,Diagnostic reagents,Technology development of medical devices,technology transfer,Technical Training,Technical Services;Biotechnology Information Consulting;Sales of laboratory immunological reagents,laboratory apparatus;Import and export,Technology Import and Export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd (hereinafter referred to as "Zhifei Longcom ") is a high-tech enterprise which integrates the R&D, production and sales of biological products, it is a wholly owned subsidiary of Chongqing Zhifei Biological products Co., Ltd (stock code :300122). The company mainly engages in the R&D and production of biological products (immune preparations, vaccines, genetic recombination products), it has a registered capital of 765 million yuan, plant area of 216,282 m2, and it has expropriated 415.7 mu of land for the construction of bio-pharmaceutical industrial Park in Hefei Hi-tech Zone. After completion, the biopharmaceutical industrial park will be integrated with R&D, production, logistics, sales and incubation, realizing a multi-variety and large-scale production pattern.At that time, the company will become a first-class vaccine enterprise in China, effectively promote the development of hefei biomedical industry, and contribute to the realization of the goal of "healthy China".

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA.

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Boehringer Ingelheim Vetmedica GmbH, part of C.H. Boehringer Sohn AG & Co. KG, is a German company located in Ingelheim am Rhein that manufactures and sells animal vaccines and pharmaceuticals. Stephan Günther Dolle and Dana Leskova are the current co-CEOs of the firm.

Adcock Ingram Ltd. manufactures and markets pharmaceuticals, personal care, and household hygiene products. The firm's products are used in the areas of cardiovascular, central nervous system, dermatology, diabetes, ear, nose and eye preparations, feminine health, and analgesics. The company was founded in 1890 and is headquartered in Bryanston, South Africa.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Unitika Ltd. engages in the polymer and functional materials business. It operates through the following business segments: Polymer, Functional Material, Fiber, and Others. The Polymer segment manufactures and sells plastic film, resin, and non-woven cloth. The Functional Material segment handles the manufacture and sale of glass fibers. The Fiber segment deals with the manufacture and sale of various fibers such as thread, cotton, and knitted fibers. The Others segment includes environmental business, medical business, lifestyle and wellness, and real estate businesses. The company was founded on June 19, 1889 and is headquartered in Osaka, Japan.

Shanghai Chuanghong Biotechnology Co., Ltd., established on 2007-08-28, The scope of business includes technical consulting in the field of biotechnology,technology development,Technical Services,technology transfer;Quality inspection technical service;sell pet supplies,Feed and Feed Additives;Medical device management;Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Anhui Biopharmaceutical Co., Ltd., established on 1993-12-03, Business scope includes biologics,Western medicine preparation manufacturing,Development of packaging materials,Manufacturing and Sales,Experimental Animal Breeding,veterinary medicine,Veterinary Medical Devices,Feed additives.